 |
Technical Data |
|
V2110-16Y |
VEGFR1, Recombinant, Human (Vascular Endothelial Growth Factor Receptor 1, VEGFR-1, Fms-like Tyrosine Kinase 1, FLT-1, Tyrosine-protein Kinase FRT, Tyrosine-protein Kinase Receptor FLT, Vascular Permeability Factor Receptor, FLT1, FLT, FRT) |
10ug |
| Growth Factors, Cytokines | Storage: -20°CShipping: Blue Ice |
|
VEGFR-1 belongs to a family of five receptor tyrosine kinase receptors that are specific to a number of angiogenic factors including VEGF and PDGF, and are therefore thought to play a role in the angiogenic process. VEGFR-1 is expressed in two forms, predominantly on endothelial cells, giving rise to a full-length membrane bound receptor and a truncated soluble receptor. Elevated levels of the soluble form of this VEGF receptor may be used in the diagnosis of pathological conditions. Source: Recombinant corresponding to aa31-328 from human VEGFR, fused to 6x His-tag at N-terminal, expressed in E. coli. Applications: Suitable for use in Western Blot as a control. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. |
Source: E. coli Purity: Purified (SDS-PAGE). Concentration: As reported Form: Supplied as a liquid in 25mM Tris-HCl, pH6.8, 50mM DTT, 1% SDS, 0.1% Bromophenol Blue, 2.5% glycerol. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
1. Starovasnik, M. A et al. (1999) J. Mol. Biol. 296 (3): 531- 544. 2. Kanno, S. et al. (2000) Oncogene 19 (17): 2138-2146.
|
||